MATX 34.27 Matson Inc $MATX Hit a 52 week high of 34.44

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 1:26 PM

MATX 34.27 Matson Inc $MATX Hit a 52 week high of 34.44 Closing the day 09:45 at 34.27 +0.03 +0.09% With a day low of 33.87 and a total volume of 23,913.

MATX Recent Posts: http://investorshangout.com/Matson-Inc-MATX-90043/

MATX Matson Inc Recent Headline News

HRZL INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of Horizon Lines, Inc. Regarding the Fairness of the Sale of the Company to Matson, Inc. -- HRZL
PR Newswire - 1 hr 53 mins ago
Levi & Korsinsky is investigating the Board of Directors of Horizon Lines, Inc. ("Horizon Lines" or "the Company"

(OTC: HRZL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Matson, Inc. (NYSE: MATX).
MATX: 34.45 (+0.21)

NYSE stocks posting largest volume increases
AP - Thu Nov 13, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
CODI: 16.89 (-0.17), CVO: 1.79 (-0.11), FCE.A: 21.48 (+0.10), RYN: 26.00 (-0.13), EVDY: 13.50 (-0.48), TRUP: 6.60 (-0.10), MATX: 34.45 (+0.21), ZTS: 43.17 (-0.07), RCAP: 11.63 (+0.28), TCI: 12.93 (+0.02), AME: 51.79 (+1.47), AGM: 30.25 (-0.23)

NYSE stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
CJES: 19.86 (-0.02), AEO: 13.59 (+0.01), EVDY: 13.50 (-0.48), VSLR: 11.95 (+0.25), MTOR: 14.01 (-0.13), TWTR: 41.59 (+1.55), CRCM: 8.86 (-0.11), GNW: 9.24 (-0.06), MATX: 34.45 (+0.21), CSH: 24.69 (-0.02), BHI: 58.91 (+0.16)

HORIZON SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Matson
Business Wire - Thu Nov 13, 10:37AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Horizon Lines, Inc. ("Horizon"

(Other OTC: HRZL) concerning the sale to Matson, Inc. Under the terms of the agreement Horizon shareholders will only receive $0.72 in cash for each share owned, which is well below the 52-week high of $1.12 and at least one analyst's estimated value of $8 per share.
MATX: 34.45 (+0.21)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of Horizon Lines, Inc. Regarding the Fairness of the Sale of the Company to Matson, Inc.
Business Wire - Wed Nov 12, 5:42PM CST
Levi & Korsinsky is investigating the Board of Directors of Horizon Lines, Inc. ("Horizon Lines" or "the Company"

(OTC:HRZL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Matson, Inc. (NYSE:MATX).
MATX: 34.45 (+0.21)

Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Horizon Lines, Inc. May Not Be In the Best Interests of Its Investors
PR Newswire - Wed Nov 12, 3:04PM CST
Wolf Popper LLP is investigating claims on behalf of investors in Horizon Lines, Inc. (OTC: HRZL), concerning the proposed acquisition of Horizon by Matson, Inc. (NYSE: MATX). Horizon shareholders seeking more information about this acquisition are advised to contact Carl Stine at (212) 759-4600 or cstine@wolfpopper.com.
MATX: 34.45 (+0.21)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:45AM CST

LTBR: 1.95 (-0.10), ASPS: 51.52 (-3.48), AETI: 5.89 (+0.13), PLUG: 3.76 (-0.30), MOC: 1.88 (-0.07), CRDS: 2.72 (+0.15), STKL: 12.18 (-0.09), BIOC: 3.34 (-0.12), CZR: 16.92 (+0.41), MATX: 34.45 (+0.21), NTIC: 20.00 (-0.75), SDPI: 5.30 (+0.05), RESN: 7.19 (unch), OREX: 5.63 (-0.23), FLL: 1.21 (unch), VGGL: 2.74 (-0.18), CGG: 9.25 (+0.56), SUSQ: 13.09 (+0.03), SINO: 1.81 (unch), ELMD: 2.08 (+0.08)

Matson skies after striking strategic deal
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:43AM CST

MATX: 34.45 (+0.21)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Horizon Lines, Inc. Concerning its Proposed Sale to Matson, Inc.
Business Wire - Wed Nov 12, 10:52AM CST
The Rosen Law Firm announces that it is investigating the Board of Directors of Horizon Lines, Inc. (OTC:HRZL) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Horizon Lines to maximize shareholder value before agreeing to be acquired by Matson, Inc. (NYSE: MATX).
MATX: 34.45 (+0.21)

Matson (MATX) Is Today's Strong On High Volume Stock
at The Street - Wed Nov 12, 9:03AM CST
Trade-Ideas LLC identified Matson (MATX) as a strong on high relative volume candidate
MATX: 34.45 (+0.21)

Hawaii shipping company buys Alaska business
By AUDREY McAVOY - AP - Tue Nov 11, 5:27PM CST
HONOLULU (AP) — The shipping company with the largest share of the Hawaii market said Tuesday it will buy the Alaska operations of its competitor.
MATX: 34.45 (+0.21)

Matson to acquire Horizon Lines' Alaska operations in $456M deal
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 5:19PM CST

MATX: 34.45 (+0.21)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 4:38PM CST

HEAR: 3.95 (-0.08), FOSL: 108.05 (-1.76), SUPN: 8.49 (unch), ESSA: 11.58 (-0.04), YDLE: 13.19 (-0.11), LVS: 63.11 (+0.28), GOL: 4.96 (-0.23), OPWR: 16.26 (-0.79), KKD: 20.05 (-0.03), MATX: 34.45 (+0.21)

Horizon Lines Terminating Puerto Rico Operations
PR Newswire - Tue Nov 11, 3:02PM CST
Horizon Lines, Inc. (OTCQB: HRZL) ("Horizon Lines" or the "Company"

today announced that it would cease providing liner service between the U.S. and Puerto Rico by the end of 2014 due to continuing losses without the prospect of future profitability.
MATX: 34.45 (+0.21)

Horizon Lines To Be Acquired By Matson For $0.72 Per Share In Cash
PR Newswire - Tue Nov 11, 3:01PM CST
Horizon Lines, Inc. (OTCQB: HRZL) ("Horizon"

today announced it has entered into definitive agreements with each of Matson Inc. (NYSE: MATX) ("Matson"

and The Pasha Group ("Pasha"

. Under the Matson agreement, Matson will acquire all outstanding shares of Horizon Lines for $0.72 per share in an all-cash transaction. The acquisition price represents a premium of approximately 89% over Horizon's closing stock price on November 10, 2014. The Matson agreement has been unanimously approved by Horizon's Board of Directors and Horizon shareholders representing 55% of the fully diluted equity, which also represents 41% of the outstanding voting common stock on November 11, 2014, have agreed to vote their shares in support of the transaction.
MATX: 34.45 (+0.21)

Matson To Acquire Horizon's Alaska Operations
PR Newswire - Tue Nov 11, 3:01PM CST
Matson, Inc. (NYSE: MATX) and Horizon Lines, Inc. (OTCQB: HRZL) today announced that they have entered into a definitive merger agreement pursuant to which Matson will acquire the stock of Horizon, which will include its Alaska operations and the assumption of all non-Hawaii business liabilities (the "Transaction"

. Separately, Horizon today also announced that it has agreed to sell its Hawaii operations to The Pasha Group for $141.5 million (the "Hawaii Business Sale"

and intends to shut down its Puerto Rico liner operations by the end of 2014.
MATX: 34.45 (+0.21)

Matson, Inc. Q3 2014 Earnings Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:28AM CST

MATX: 34.45 (+0.21)

Matson tops Street 3Q forecasts
Automated Insights - Thu Nov 06, 5:54PM CST
HONOLULU (AP) _ Matson Inc. (MATX) on Thursday reported profit of $21.5 million in its third quarter.
MATX: 34.45 (+0.21)

Matson beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:40PM CST

MATX: 34.45 (+0.21)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...